Azithromycin/chloroquine-diphosphateDrug ineffectiveness following off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1966卷 / 1期

关键词：

D O I：

10.1007/s40278-023-43540-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：87 / 87

相关论文

共 50 条

[31] DapsoneMethaemoglobinaemia following off-label use: case report
Reactions Weekly, 2021, 1843 (1) : 130 - 130
[32] NalbuphineBradycardia following an off-label use: case report
Reactions Weekly, 2019, 1753 (1) : 255 - 255
[33] DimeticoneGranuloma following off-label use: case report
Reactions Weekly, 2023, 1980 (1) : 150 - 150
[34] CyproteroneMeningiomas following off-label use: case report
Reactions Weekly, 2021, 1849 (1) : 152 - 152
[35] SildenafilHypotension following off-label use: case report
Reactions Weekly, 2025, 2045 (1) : 376 - 376
[36] Azithromycin/methylprednisoloneHyperglycaemia following off label use: case report
Reactions Weekly, 2020, 1828 (1) : 107 - 107
[37] DenosumabHypocalcaemia following off-label use: case report
Reactions Weekly, 2022, 1923 (1) : 178 - 178
[38] SirolimusNeutropenia following off-label use: case report
Reactions Weekly, 2023, 1960 (1) : 394 - 394
[39] RisperidonePancreatitis following off-label use: case report
Reactions Weekly, 2022, 1934 (1) : 378 - 378
[40] CyclophosphamideMyelosuppression following off-label use: case report
Reactions Weekly, 2020, 1835 (1) : 116 - 116

← 1 2 3 4 5 →